Shopping Basket

Your basket is empty
A multi-centre clinical trial conducted in China has found that a Chinese herbal formula may have therapeutic value in patients with both hypertension and metabolic syndrome, comparing favourably with the anti-hypertension drug irbesartan.

    • Please note that: the most twenty most recent research abstracts are free to view but access to the thousands of items in the archive require a journal subscription .

Not yet subscribed?

Subscribe to the Journal of Chinese Medicine now from only £30.00 per year. Your subscription will include:

Subscribe now